NephRx Newsroom

November 01, 2008:   The Biosciences Research and Commercialization Center (BRCC), announced it’s continuing support of NephRx Corporation by providing $200,000 in additional funding for development of the Company’s two peptides. The BRCC, established in 2003 .... Read more

October 01, 2008:   Patrick G. Morand is Managing Director of the SWMF Life Science Fund, headquartered in Kalamazoo, Michigan. Prior to joining the Fund, Mr. Morand was Executive in Residence of the Pittsburgh Life Sciences Greenhouse, a Public/Private investor in regi .... Read more

September 01, 2008:   After an extensive search, NephRx Corporation announced the hiring of William McGinnis as President and CEO. McGinnis has extensive experience in the biosciences having served as President and CEO of several Canadian and United States biotechnology s .... Read more

August 01, 2008:   The Southwest Michigan First Life Sciences Fund announced an additional $2 million in funding to support further development of NX001, the Company’s treatment for acute kidney disease. Patrick Morand, Managing Director of the Life Sciences Fund .... Read more